Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 17;18(1):30.
doi: 10.1186/s12880-018-0275-3.

Apparent diffusion coefficient as an effective index for the therapeutic efficiency of brain chemoradiotherapy for brain metastases from lung cancer

Kai Liu  1 , Zenglin Ma  2 , Lili Feng  1
Affiliations

Apparent diffusion coefficient as an effective index for the therapeutic efficiency of brain chemoradiotherapy for brain metastases from lung cancer

Kai Liu et al. BMC Med Imaging. .

Abstract

Background: The potential of apparent diffusion coefficient (ADC) value alteration before and after chemoradiotherapy as a potential monitor for therapeutic efficiency of treatment for brain metastases from lung cancer were discussed.

Method: Thirty lung cancer patients with brain metastases, conventional magnetic resonance imaging (MRI) examination and diffusion weighted imaging (DWI) were performed one week before chemoradiotherapy and after one treatment cycle and two treatment cycles. 43 tumor lesions were divided into effective group and invalid group according to the changes of the tumor size. The differences in ADC values at different time points before and after treatment in each treatment group were analyzed.

Result: The maximum diameter of the tumor was no difference after one treatment cycle, but decreased after two treatment cycles. ADC values significantly increased after both one and two treatment cycles. In effective group, the ADC values were significantly increased after one and two treatment cycles. While, there are no difference in invalid group after one treatment cycle but decreased after two treatment cycles. ΔADC values in effective group after one and two treatment cycles were both significantly higher than those in the invalid group. ROC curve analysis then revealed that the area under the curve (AUC) of ΔADC after one treatment was 0.872.

Conclusion: ADC values in brain metastases from lung cancer can help monitor and dynamically observe the therapeutic efficiency of whole brain chemoradiotherapy.

Keywords: Apparent diffusion coefficient (ADC); Brain metastases; Magnetic resonance imaging (MRI); Therapeutic efficiency.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethic Committee of The Third Affiliated Hospital of Beijing University of Chinese Medicine. All of the enrolled patients signed informed consent forms.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interest.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
ADC values indicate the tumor progression more sensitively than MRI (a) The maximum diameters of tumors for brain metastases from lung cancer before and after treatments. b ADC values of brain metastases from lung cancer before and after treatments. n = 43, p < 0.05 statistical significance compared to one week before treatment
Fig. 2
Fig. 2
Two cases were shown below for example the group division: Case 1: Pathologically diagnosed as brain metastases from right lung adenocarcinoma. The maximum diameter of the lesion was 10 mm one week before treatment and the ADC value was 0.653 × 10− 3 mm2/s; the maximum diameter of the lesion was 12 mm and the ADC value was 0.733 × 10− 3 mm2/s after one treatment cycle; the maximum diameter of the lesion was 14 mm and the ADC value was 0.706 × 10− 3 mm2/s after two treatment cycles. According to RECIST criteria, the patient belonged to the invalid group. Case 2: pathologically diagnosed as brain metastases from lung cancer. The lesions on the right occipital lobe were nodular with slightly higher signal intensity on T2WI, slightly lower signal intensity on T1WI, high signal intensity on DWI, and obviously enhanced lesions on contrast-enhanced T1WI. The maximum diameter was 17 mm before treatment and the ADC value was 0.759 × 10− 3 mm2/s; after one treatment cycle, the maximum diameter of the lesion was reduced to about 16 mm, and the ADC value was 1.05 × 10− 3 mm2/s; after two treatment cycles, the enhanced part of the lesion was obviously reduced, with a diameter of 3 mm, and the ADC value was 1.10 × 10− 3 mm2/s, suggesting that the treatment was effective. According to RECIST criteria, this patient belongs to the effective group.
Fig. 3
Fig. 3
ROC curve analysis of ΔADC values after one treatment cycle. The AUC was 0.872 (sensitivity = 81.8%, specificity = 85.7%)
See this image and copyright information in PMC

References

    1. Jenkinson MD, Haylock B, Shenoy A, Husband D, Javadpour M. Management of cerebral metastasis: evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy. Eur J Cancer. 2011;47(5):649–655. doi: 10.1016/j.ejca.2010.11.033. - DOI - PubMed
    1. Nussbaum ES, Djalilian HR, Cho KH, Hall WA. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer. 1996;78(8):1781–1788. doi: 10.1002/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.0.CO;2-U. - DOI - PubMed
    1. Auperin A, Arriagada R, Pignon JP, Le Pechoux C, Gregor A, Stephens RJ, Kristjansen PE, Johnson BE, Ueoka H, Wagner H, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group. N Engl J Med. 1999;341(7):476–484. doi: 10.1056/NEJM199908123410703. - DOI - PubMed
    1. Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol. 2011;29(3):272–278. doi: 10.1200/JCO.2010.29.1609. - DOI - PMC - PubMed
    1. Brufsky AM, Mayer M, Rugo HS, Kaufman PA, Tan-Chiu E, Tripathy D, Tudor IC, Wang LI, Brammer MG, Shing M, et al. Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER. Clin Cancer Res. 2011;17(14):4834–4843. doi: 10.1158/1078-0432.CCR-10-2962. - DOI - PubMed

Publication types